{
  "nct_id": "NCT28367867",
  "indication": "Rheumatoid Arthritis",
  "phase": "Phase 2",
  "sample_size": 114,
  "duration_weeks": 47,
  "dropout_rate": 0.09,
  "primary_endpoints": [
    "Joint damage progression"
  ],
  "secondary_endpoints": [
    "Joint damage progression",
    "DAS28 score reduction"
  ],
  "blinding": "open-label",
  "control_arm": "active comparator",
  "outcome_summary": "Study did not demonstrate sufficient efficacy.",
  "success": false,
  "failure_reason": "Endpoint selection issues"
}